XYL
43
-4
CRM
59
4
ACN
65
4
MDLZ
36
4
RL
76
-3
BF.B
53
5
AA
38
3
MMM
30
2
KR
50
10
COST
69
-4
SIG
47
-3
AAPL
56
-3
LYB
32
2
MCHP
52
3
VMC
57
3
ILMN
36
10
CSCO
53
2
K
30
-2
EFX
55
-2
O
37
-2
XYL
43
-4
CRM
59
4
ACN
65
4
MDLZ
36
4
RL
76
-3
BF.B
53
5
AA
38
3
MMM
30
2
KR
50
10
COST
69
-4
SIG
47
-3
AAPL
56
-3
LYB
32
2
MCHP
52
3
VMC
57
3
ILMN
36
10
CSCO
53
2
K
30
-2
EFX
55
-2
O
37
-2
Financhill
Back

PAVmed Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
18

PAVM
PAVmed

Last Price:
0.85
Seasonality Move:
13.54%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
18
PAVmed (PAVM) is a Sell

Is PAVmed a Buy, Sell or Hold?

  • The current PAVmed [PAVM] share price is $0.84. The Score for PAVM is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • PAVM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PAVM Stock Price Chart

What is PAVmed's stock price today?

  • The PAVmed share price today is $0.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PAVM is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PAVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 23.92 Sell
Chaikin Money Flow: -21668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.02 - 1.68) Sell
Bollinger Bands (100): (1.48 - 2.4) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PAVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1 Sell
20-day SMA: 1.23 Sell
50-day SMA: 1.67 Sell
200-day SMA: 3 Sell
8-day EMA: 0.99 Sell
20-day EMA: 1.22 Sell
50-day EMA: 1.59 Sell
200-day EMA: 3.22 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

PAVmed Earnings Growth & PAVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $0.06 per share, an increase this year of $0.97 per share, and an increase next year of $0.16 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

PAVmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):